Mar. 24, 2023

GLPG2534: What Happened to IRAK4? A Galapagos Case Study

GLPG2534

oral IRAK4 inhibitor promising activity in mouse model for atopic dermatitis HTS of kinase-focused 25K cmpd library vs. IRAK4 catalytic domain Sci. Trans. Med., February 15, 2023 Galapagos, FR + BE

twitterlinkedinprintemail

MOTY Nominees

Molecule of the Year